Page 54 - Read Online
P. 54

Page 8 of 14                   Zhang et al. Vessel Plus 2021;5:48  https://dx.doi.org/10.20517/2574-1209.2021.64

               this reason, efforts to try to correct any specific dysregulated angiogenic signaling, rooted from deficiency in
               any CCMs, to alleviate CCM lesion burden or even prevent hemorrhagic CCMs might eventually prove to
               be too little too late [Figure 1].


               DECLARATIONS
               Authors’ contributions
               Conceptualization, methodology, writing original draft preparation, reviewing and editing: Zhang J
               Writing, reviewing and editing: Abou-Fadel JS

               Availability of data and materials
               Not applicable.

               Financial support and sponsorship
               None.

               Conflicts of interest
               Both authors declared that there are no conflicts of interest.

               Ethical approval and consent to participate
               Not applicable.


               Consent for publication
               Not applicable.


               Copyright
               © The Author(s) 2021.


               REFERENCES
               1.       Rigamonti D, Drayer BP, Johnson PC, Hadley MN, Zabramski J, Spetzler RF. The MRI appearance of cavernous malformations
                    (angiomas). J Neurosurg 1987;67:518-24.  DOI  PubMed
               2.       Otten P, Pizzolato GP, Rilliet B, Berney J. 131 cases of cavernous angioma (cavernomas) of the CNS, discovered by retrospective
                    analysis of 24,535 autopsies. Neurochirurgie 1989;2:82-3,128.  PubMed
               3.       Moriarity JL, Clatterbuck RE, Rigamonti D. The natural history of cavernous malformations. Neurosurg Clin N Am 1999;10:411-7.
                    PubMed
               4.       Curling O Jr, Kelly DL Jr, Elster AD, Craven TE. An analysis of the natural history of cavernous angiomas. J Neurosurg
                    1991;75:702-8.  DOI  PubMed
               5.       Batra S, Lin D, Recinos PF, Zhang J, Rigamonti D. Cavernous malformations: natural history, diagnosis and treatment. Nat Rev
                    Neurol 2009;5:659-70.  DOI  PubMed
               6.       Rigamonti D, Spetzler RF, Drayer BP, et al. Appearance of venous malformations on magnetic resonance imaging. J Neurosurg
                    1988;69:535-9.  DOI  PubMed
               7.       Dubovsky J, Zabramski JM, Kurth J, et al. A gene responsible for cavernous malformations of the brain maps to chromosome 7q.
                    Hum Mol Genet 1995;4:453-8.  DOI  PubMed
               8.       Marchuk DA, Gallione CJ, Morrison LA, et al. A locus for cerebral cavernous malformations maps to chromosome 7q in two
                    families. Genomics 1995;28:311-4.  DOI  PubMed
               9.       Günel M, Awad IA, Finberg K, et al. Genetic heterogeneity of inherited cerebral cavernous malformation. Neurosurgery
                    1996;38:1265-71.  DOI  PubMed
               10.       Günel M, Awad IA, Anson J, Lifton RP. Mapping a gene causing cerebral cavernous malformation to 7q11.2-q21. Proc Natl Acad
                    Sci U S A 1995;92:6620-4.  DOI  PubMed  PMC
               11.       Johnson EW, Iyer LM, Rich SS, et al. Refined localization of the cerebral cavernous malformation gene (CCM1) to a 4-cM interval
                    of chromosome 7q contained in a well-defined YAC contig. Genome Res 1995;5:368-80.  DOI  PubMed
               12.       Craig HD, Günel M, Cepeda O, et al. Multilocus linkage identifies two new loci for a mendelian form of stroke, cerebral cavernous
                    malformation, at 7p15-13 and 3q25.2-27. Hum Mol Genet 1998;7:1851-8.  DOI  PubMed
               13.       Laberge-le Couteulx S, Jung HH, Labauge P, et al. Truncating mutations in CCM1, encoding KRIT1, cause hereditary cavernous
                    angiomas. Nat Genet 1999;23:189-93.  DOI  PubMed
   49   50   51   52   53   54   55   56   57   58   59